Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review

Spinal and Supraspinal Contributions to Central Sensitization in Peripheral Neuropathy

Suzuki R. · Dickenson A.

Author affiliations

Department of Pharmacology, University College London, London, UK

Corresponding Author

Rie Suzuki, PhD

Department of Pharmacology, Medical Sciences Building

University College London, Gower Street

London WC1E 6BT (UK)

Tel. +44 207 679 3737, Fax +44 207 679 3742, E-Mail ucklrsu@ucl.ac.uk

Related Articles for ""

Neurosignals 2005;14:175–181

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

We will focus on spinal cord dorsal horn lamina I projection neurones, their supraspinal targets and involvement in pain processing. These spinal cord neurons respond to tonic peripheral inputs by wind-up and other intrinsic mechanisms that cause central hyper-excitability, which in turn can further enhance afferent inputs. We describe here another hierarchy of excitation – as inputs arrive in lamina I, neurones rapidly inform the parabrachial area (PBA) and periaqueductal grey (PAG), areas associated with the affective and autonomic responses to pain. In addition, PBA can connect to areas of the brainstem that send descending projections down to the spinal cord – establishing a loop. The serotonin receptor, 5HT3, in the spinal cord mediates excitatory descending inputs from the brainstem. These descending excitatory inputs are needed for the full coding of polymodal peripheral inputs from spinal neurons and are enhanced after nerve injury. Furthermore, activity in this serotonergic system can determine the actions of gabapentin (GBP) that is widely used in the treatment of neuropathic pain. Thus, a hierarchy of separate, but interacting excitatory systems exist at peripheral, spinal and supraspinal sites that all converge on spinal neurones. The reciprocal relations between pain, fear, anxiety and autonomic responses are likely to be subserved by these spinal-brainstem-spinal pathways we describe here. Understanding these pain pathways is a first step toward elucidating the complex links between pain and emotions.

© 2005 S. Karger AG, Basel


References

  1. Wang H, Sun H, Della Penna K, Benz R, Xu J, Gerhold D, Holder D, Koblan K: Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 2002;114:529–546.
  2. Garry M, Tanelian D: Afferent activity in injured afferent nerves; in Yaksh T, Lynch C, Zapol W, Maze M, Biebuyck J, Saidman L (eds): Anesthesia. Biologic Foundations. Philadelphia, Lippincott-Raven, 1997, pp 531–542.
  3. Suzuki R, Dickenson A: Neuropathic pain: nerves bursting with excitement. Neuroreport 2000;11:R17–R21.
    External Resources
  4. Sorkin L, Carlton S: Spinal anatomy and pharmacology of afferent processing; in Yaksh T, Lynch C, Zapol W, Maze M, Biebuyck J, Saidman L (eds): Anesthesia. Biologic Foundations. Philadelphia, Lippincott-Raven, 1997, pp 577–610.
  5. Todd A: Anatomy of primary afferents and projection neurones in the rat spinal dorsal horn with particular emphasis on substance P and the neurokinin 1 receptor. Expl Physiol 2002;87:245–249.
  6. Woolf C, Fitzgerald M: The properties of neurones recorded in the superficial dorsal horn of the rat spinal cord. J Comp Neurol 1983;221:313–328.
  7. Craig A, Dostrovsky J: Differential projections of thermoreceptive and nociceptive lamina I trigeminothalamic and spinothalamic neurons in the cat. J Neurophysiol 2001;86:856–870.
  8. Marshall GE, Shehab SA, Spike RC, Todd AJ: Neurokinin-1 receptors on lumbar spinothalamic neurons in the rat. Neuroscience 1996;72:255–263.
  9. Light A, Sedivec M, Casale E, Jones S: Physiological and morphological characteristics of spinal neurones projecting to the parabrachial region of the cat. Somatosens Mot Res 1993;10:309–325.
  10. Hylden JL, Anton F, Nahin RL: Spinal lamina I projection neurons in the rat: collateral innervation of parabrachial area and thalamus. Neuroscience 1989;28:27–37.
  11. Wall P, Bery J, Saade N: Effects of lesions to rat spinal cord lamina I cell projection pathways on reactions to acute and chronic noxious stimuli. Pain 1988;35:327–339.
  12. Gauriau C, Bernard J: Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002;87:251–258.
  13. Bester H, Menendez L, Besson J, Bernard J: Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes. J Neurophysiol 1995;73:568–585.
  14. Hunt S, Mantyh P: The molecular dynamics of pain control. Nat Rev 2001;2:83–91.
  15. Fields HL: Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 2000;122:245–253.
  16. Millan MJ: Descending control of pain. Prog Neurobiol 2002;66:355–474.
  17. Urban M, Gebhart G: Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999;95:2630–2635.
  18. Zhuo M, Gebhart G: Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J Neurophysiol 1997;78:746–758.
  19. Urban MO, Gebhart GF: Characterisation of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla. J Neurophysiol 1997;78:1550–1562.
  20. Dickenson AH: A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990;11:307–309.
  21. Herrero J, Laird J, Lopez-Garcia J: Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 2000;61:169–203.
  22. Mantyh P, Rogers S, Honore P, Allen B, Ghilardi J, Li J, Daughters R, Lappi D, Wiley R, Simone D: Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997;278:275–279.
  23. Suzuki R, Morcuende S, Webber M, Hunt S, Dickenson A: Superficial NK1 expressing neurones control spinal excitability by activation of descending pathways. Nat Neurosci 2002;5:1319–1326.
  24. Todd AJ, Spike RC, Polgar E: A quantitative study of neurons which express neurokinin-1 or somatostatin sst2a receptor in rat spinal dorsal horn. Neuroscience 1998;85:459–473.
  25. Morales M, Battenberg E, Bloom FE: Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord. J Comp Neurol 1998;402:385–401.
  26. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D: Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991;254:432–437.
  27. Zeitz K, Guy N, Malmberg A, Dirajlal S, Martin W, Sun L, Bonhaus D, Stucky C, Julius D, Basbaum A: The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002;22:1010–1019.
  28. Green G, Scarth J, Dickenson A: An excitatory role for 5-HT in spinal inflammatory nociceptive transmission: state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized rat. Pain 2000;89:81–88.
  29. Ali Z, Wu G, Kozlov A, Barasi S: The role of 5-HT3 in antinociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996;208:203–207.
  30. Rygh L, Kontinen V, Suzuki R, Dickenson A: Different increase in C-fibre evoked responses after nociceptive conditioning stimulation in sham-operated and neuropathic rats. Neurosci Lett 2000;288:99–103.
  31. Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J: Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 2003;299:1237–1240.
  32. Willis W: Long-term potentiation in spinothalamic neurons. Brain Res Rev 2002;40:202–214.
  33. Ossipov M, Lai J, Malan TJ, Porreca F: Spinal and supraspinal mechanisms of neuropathic pain. Ann NY Acad Sci 2000;909:12–24.
  34. Dickenson A, Matthews E, Suzuki R: Central nervous system mechanisms of pain in peripheral neuropathy; in Hansson P, Fields H, Hill R, Marchettini P (eds): Neuropathic Pain: Pathophysiology and Treatment. Seattle, IASP Press, 2001, pp 85–106.
  35. Zimmermann M: Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23–37.
  36. Burgess S, Gardell L, Ossipov M, Malan T Jr, Vanderah T, Lai J, Porreca F: Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 2002;22:5129–5136.
  37. Porreca F, Ossipov M, Gebhart G: Chronic pain and medullary descending facilitation. Trends Neurosci 2002;25:319–325.
  38. Heinricher M, Roychowdhury S: Reflex-related activation of putative pain facilitating neurones in rostral ventromedial medulla requires excitatory amino acid transmission. Neuroscience 1997;78:1159–1165.
  39. Monassi CR, Bandler R, Keay KA: A subpopulation of rats show social and sleep-waking changes typical of chronic neuropathic pain following peripheral nerve injury. Eur J Neurosci 2003;17:1907–1920.
  40. Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, Kotter I, Zoller B, Peter H, Neeck G, Alten R, Muller W: Efficacy and tolerability of tropisetron in primary fibromyalgia: a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol Suppl 2000;113:49–54.
  41. Hicks GA, Coldwell JR, Schindler M, Ward PA, Jenkins D, Lynn PA, Humphrey PP, Blackshaw LA: Excitation of rat colonic afferent fibres by 5-HT(3) receptors. J Physiol 2002;544:861–869.
  42. Bian D, Ossipov MH, Zhong C, Malan TP, Jr., Porreca F: Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci Lett 1998;241:79–82.
  43. Nayak SV, Ronde P, Spier AD, Lummis SC, Nichols RA: Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain. Neuroscience 1999;91:107–117.
  44. Jones S, Yakel J: Ca2+ influx through voltage-gated Ca2+ channels regulates 5-HT3 receptor channel desensitization in rat glioma x mouse neuroblastoma hybrid NG108-15 cells. J Physiol 1998;510:361–370.
  45. Nicholson B: Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000;101:359–371.
  46. Serpell MG: Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 2002;99:557–566.
  47. Backonja MM: Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59:S14–S17.
  48. Rose MA, Kam PC: Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57:451–462.
  49. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN: The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768–5776.
  50. Field MJ, Hughes J, Singh L: Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000;131:282–286.
  51. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L: Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997;121:1513–1522.
  52. Abdi S, Lee DH, Chung JM: The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998;87:1360–1366.
  53. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ: The effect of novel anti epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997;324:153–160.
  54. Erichsen HK, Blackburn-Munro G: Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 2002;98:151–161.
  55. Hwang JH, Yaksh TL: Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 1997;22:249–256.
  56. Yoon MH, Yaksh TL: The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg 1999;89:434–439.
  57. Christensen D, Gautron M, Guilbaud G, Kayser V: Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 2001;93:147–153.
  58. Spike RC, Puskar Z, Sakamoto H, Stewart W, Watt C, Todd AJ: MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli. Eur J Neurosci 2002;15:1306–1316.
  59. Mccleane G, Suzuki R, Dickenson A: Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth Analg 2003;97:1474–1478.
  60. Suzuki R, Rahman W, Hunt S, Dickenson A: Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res 2004;1019:68–76.

Article / Publication Details

First-Page Preview
Abstract of Review

Published online: October 13, 2005
Issue release date: October 2005

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 0

ISSN: 1424-862X (Print)
eISSN: 1424-8638 (Online)

For additional information: https://www.karger.com/NSG


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.